BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35331591)

  • 1. Intraoperative pancreatoscopy in pancreaticoduodenectomy for intraductal papillary mucinous neoplasms of the pancreas: Application to the laparoscopic approach.
    Yang HY; Kang I; Hwang HK; Lee WJ; Kang CM
    Asian J Surg; 2023 Jan; 46(1):166-173. PubMed ID: 35331591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Intraoperative Pancreatoscopy with Intraductal Biopsies on Surgical Management of Intraductal Papillary Mucinous Neoplasm of the Pancreas.
    Navez J; Hubert C; Gigot JF; Borbath I; Annet L; Sempoux C; Lannoy V; Deprez P; Jabbour N
    J Am Coll Surg; 2015 Nov; 221(5):982-7. PubMed ID: 26304184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of conservative surgery for pancreatic IPMNs.
    Palmeri M; Di Franco G; Bianchini M; Guadagni S; Gianardi D; Furbetta N; Caprili G; Fatucchi LM; Sbrana A; Funel N; Pollina LE; Di Candio G; Morelli L
    Surg Oncol; 2021 Sep; 38():101582. PubMed ID: 33892432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological evaluation of resected intraductal papillary mucinous neoplasms reveals distinct patterns of invasion in associated carcinomas.
    Rift CV; Lund EL; Scheie D; Hansen CP; Hasselby JP
    Hum Pathol; 2021 Jul; 113():47-58. PubMed ID: 33915115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of intraoperative pancreatoscopy in the surgical management of intraductal papillary mucinous neoplasms of the pancreas: a systematic scoping review.
    Ciprani D; Frampton A; Amar H; Oppong K; Pandanaboyana S; Aroori S
    Surg Endosc; 2023 Dec; 37(12):9043-9051. PubMed ID: 37907657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
    Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
    Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct.
    Sahora K; Fernández-del Castillo C; Dong F; Marchegiani G; Thayer SP; Ferrone CR; Sahani DV; Brugge WR; Warshaw AL; Lillemoe KD; Mino-Kenudson M
    Surgery; 2014 Sep; 156(3):611-21. PubMed ID: 25081232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
    Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
    Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical Management of Main Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas.
    Dal Borgo C; Perri G; Borin A; Marchegiani G; Salvia R; Bassi C
    Dig Surg; 2019; 36(2):104-110. PubMed ID: 29421807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Intraductal Papillary Mucinous Neoplasms With Dilatation of the Main Pancreatic Duct.
    Hamada T; Oyama H; Nakai Y; Tange S; Arita J; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kawaguchi Y; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Tanaka M; Tateishi K; Ushiku T; Hasegawa K; Fujishiro M
    Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1792-1801.e3. PubMed ID: 36787835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Main Duct Thresholds for Malignancy Are Different in Intraductal Papillary Mucinous Neoplasms of the Pancreatic Head and Body-Tail.
    Crippa S; Aleotti F; Longo E; Belfiori G; Partelli S; Tamburrino D; Di Salvo F; De Cobelli F; Romano L; Arcidiacono PG; Petrone MC; Zamboni G; Lena MS; Doglioni C; Falconi M
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):390-399.e7. PubMed ID: 33385536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis.
    Manfredi R; Graziani R; Motton M; Mantovani W; Baltieri S; Tognolini A; Crippa S; Capelli P; Salvia R; Pozzi Mucelli R
    Radiology; 2009 Oct; 253(1):106-15. PubMed ID: 19703865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal papillary mucinous neoplasm--when to resect?
    Waters JA; Schmidt CM
    Adv Surg; 2008; 42():87-108. PubMed ID: 18953811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
    Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M
    Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Threshold of main pancreatic duct for malignancy in intraductal papillary mucinous neoplasm at head-neck and body-tail.
    Zhou H; Li X; Wang Y; Wang Z; Zhu J; Wang Z; Chen X
    BMC Gastroenterol; 2022 Nov; 22(1):473. PubMed ID: 36402960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes in intraductal papillary mucinous neoplasm of the pancreas and its association with malignancy.
    Zhou H; Chen X; Wang C; Lin T; Li X; Cui W; Wang J; Wang Y; Chen X
    J Surg Oncol; 2023 Mar; 127(4):625-632. PubMed ID: 36409079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of malignancy in main duct or mixed-type intraductal papillary mucinous neoplasms of the pancreas.
    Jung HS; Han Y; Kang JS; Sohn H; Lee M; Lee KB; Kim H; Kwon W; Jang JY
    J Hepatobiliary Pancreat Sci; 2022 Sep; 29(9):1014-1024. PubMed ID: 35451206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
    Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.